Evmorfia Aivalioti
About
In The Last Decade
Evmorfia Aivalioti
19 papers receiving 344 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Infectious Diseases 116
- Molecular Biology 73
- Epidemiology 73
- Immunology 61
- Neurology 50
Countries citing papers authored by Evmorfia Aivalioti
This map shows the geographic impact of Evmorfia Aivalioti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evmorfia Aivalioti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evmorfia Aivalioti more than expected).
Fields of papers citing papers by Evmorfia Aivalioti
This network shows the impact of papers produced by Evmorfia Aivalioti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evmorfia Aivalioti. The network helps show where Evmorfia Aivalioti may publish in the future.
Co-authorship network of co-authors of Evmorfia Aivalioti
This figure shows the co-authorship network connecting the top 25 collaborators of Evmorfia Aivalioti. A scholar is included among the top collaborators of Evmorfia Aivalioti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evmorfia Aivalioti. Evmorfia Aivalioti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 13 | |
| 10 | Endothelial dysfunction and immunothrombosis in sepsis breakdown → | 84 |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications breakdown → | 182 |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 8 | |
| 18 | 5 | |
| 19 | 10 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.